[go: up one dir, main page]

FI981957L - Implantoitavia agaroosikollageeni helmiä, jotka sisältävät soluja, jotka tuottavat diffundoituvaa biologista tuotetta ja niiden käyttö - Google Patents

Implantoitavia agaroosikollageeni helmiä, jotka sisältävät soluja, jotka tuottavat diffundoituvaa biologista tuotetta ja niiden käyttö Download PDF

Info

Publication number
FI981957L
FI981957L FI981957A FI981957A FI981957L FI 981957 L FI981957 L FI 981957L FI 981957 A FI981957 A FI 981957A FI 981957 A FI981957 A FI 981957A FI 981957 L FI981957 L FI 981957L
Authority
FI
Finland
Prior art keywords
produce
containing cells
biological product
beads containing
collagen beads
Prior art date
Application number
FI981957A
Other languages
English (en)
Swedish (sv)
Other versions
FI120332B (fi
FI981957A0 (fi
Inventor
Kanti Jain
Albert L Rubin
Shirin Asina
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/745,063 external-priority patent/US5888497A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of FI981957A0 publication Critical patent/FI981957A0/fi
Publication of FI981957L publication Critical patent/FI981957L/fi
Application granted granted Critical
Publication of FI120332B publication Critical patent/FI120332B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
FI981957A 1996-04-03 1998-09-11 Diffundoituvaa biologista tuotetta tuottavia soluja sisältäviä, istutettavia agaroosi-kollageenihelmiä sekä niiden käyttö FI120332B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US62559596A 1996-04-03 1996-04-03
US62559596 1996-04-03
US74506396 1996-11-07
US08/745,063 US5888497A (en) 1996-04-03 1996-11-07 Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US9704548 1997-03-21
PCT/US1997/004548 WO1997036495A1 (en) 1996-04-03 1997-03-21 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof

Publications (3)

Publication Number Publication Date
FI981957A0 FI981957A0 (fi) 1998-09-11
FI981957L true FI981957L (fi) 1998-12-02
FI120332B FI120332B (fi) 2009-09-30

Family

ID=27089961

Family Applications (1)

Application Number Title Priority Date Filing Date
FI981957A FI120332B (fi) 1996-04-03 1998-09-11 Diffundoituvaa biologista tuotetta tuottavia soluja sisältäviä, istutettavia agaroosi-kollageenihelmiä sekä niiden käyttö

Country Status (15)

Country Link
EP (2) EP1382346B1 (fi)
JP (2) JP3765039B2 (fi)
CN (2) CN1296477C (fi)
AT (2) ATE374034T1 (fi)
AU (1) AU722109C (fi)
CA (1) CA2250880C (fi)
DE (2) DE69725317T2 (fi)
DK (2) DK1382346T3 (fi)
ES (2) ES2206696T3 (fi)
FI (1) FI120332B (fi)
IL (1) IL126442A0 (fi)
NO (1) NO320334B1 (fi)
NZ (2) NZ331960A (fi)
PT (1) PT914043E (fi)
WO (1) WO1997036495A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
AU2003264652B2 (en) * 1998-11-09 2006-09-14 The Rogosin Institute Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US9283266B2 (en) 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
DK2809782T3 (da) * 2012-01-31 2017-11-20 The Rogosin Inst Inc Forbedret fremgangsmåde til fremstilling af makrokugler
KR102820005B1 (ko) 2018-02-02 2025-06-12 웨이크 포리스트 유니버시티 헬스 사이언시즈 면역요법 관련 오가노이드 및 그의 제조 및 사용 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JP2691557B2 (ja) * 1988-04-15 1997-12-17 興研株式会社 人の悪性腫瘍細胞増殖抑制剤
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5241051A (en) * 1992-04-24 1993-08-31 Research Development Foundation Oncoinhibin
RU2208636C2 (ru) * 1994-01-13 2003-07-20 Дзе Рогозин Институт Макрогранула с секреторными клетками, способ ее получения и способ лечения заболеваний, вызванных нарушением функционирования секреторных клеток
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles

Also Published As

Publication number Publication date
AU722109B2 (en) 2000-07-20
NZ331960A (en) 1999-10-28
EP1382346B1 (en) 2007-09-26
AU2218897A (en) 1997-10-22
JP2005104987A (ja) 2005-04-21
EP0914043B1 (en) 2003-10-01
EP0914043A4 (en) 2001-08-29
AU722109C (en) 2001-07-19
CA2250880A1 (en) 1997-10-09
DE69738170D1 (de) 2007-11-08
CA2250880C (en) 2008-01-15
NZ337109A (en) 2004-12-24
NO984627D0 (no) 1998-10-02
EP0914043A1 (en) 1999-05-12
NO320334B1 (no) 2005-11-21
WO1997036495A1 (en) 1997-10-09
FI120332B (fi) 2009-09-30
CN1296477C (zh) 2007-01-24
ES2206696T3 (es) 2004-05-16
NO984627L (no) 1998-11-30
CN1215309A (zh) 1999-04-28
ATE374034T1 (de) 2007-10-15
JP4480152B2 (ja) 2010-06-16
PT914043E (pt) 2004-02-27
FI981957A0 (fi) 1998-09-11
IL126442A0 (en) 1999-08-17
DK0914043T3 (da) 2004-02-09
CN1495253A (zh) 2004-05-12
HK1019037A1 (en) 2000-01-21
DK1382346T3 (da) 2008-01-28
JP3765039B2 (ja) 2006-04-12
ES2290390T3 (es) 2008-02-16
HK1066026A1 (en) 2005-03-11
DE69725317D1 (de) 2003-11-06
CN1119080C (zh) 2003-08-27
ATE250858T1 (de) 2003-10-15
JP2001503380A (ja) 2001-03-13
DE69738170T2 (de) 2008-01-24
EP1382346A1 (en) 2004-01-21
DE69725317T2 (de) 2004-07-29

Similar Documents

Publication Publication Date Title
BR9612426A (pt) Derivados carbomoilóxi e sua aplicação como antibacterianos
FI964311L (fi) Bifunktionaalinen proteiini, valmistus ja käyttö
EE04500B1 (et) Trombiini inhibiitorid, nende saamine ja kasutamine
NO993146L (no) Fremgangsmåter for fremstilling av papir og materialer for anvendelse av disse
FI965039L (fi) Uusia trombiini-inhibiittoreita, niiden valmistus ja käyttö
DE69620270D1 (de) Backfett und dessen Verwendung
FI960888A7 (fi) Protokadheriiniproteiineja ja niiden käyttö
FI940585A7 (fi) Pinnoittamattomat tabletit ja menetelmä niiden valmistamiseksi
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
ID18741A (id) Zat nikotinat dalam terapi
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
FI945166A7 (fi) Katalyttejä, niiden käyttömenetelmä ja menetelmä niiden valmistamiseksi
DE69804256D1 (de) Durchsichtiges Zellulosehydrogel und dessen Verwendung
FI953898A0 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
FI981957L (fi) Implantoitavia agaroosikollageeni helmiä, jotka sisältävät soluja, jotka tuottavat diffundoituvaa biologista tuotetta ja niiden käyttö
PL320565A1 (en) Substances and their application
PT1033990E (pt) 21-hidroxi-6,19-oxidoprogesterona (21oh-6op) e a sua utilizacao como medicamento para tratar o excesso de glucocorticoides
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
FI972494A7 (fi) Järjestelmiä ja menetelmiä biologista hajottamista varten
EE03439B1 (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
PT858445E (pt) Novos derivados de ¬(3-alcoxi-fenoxi)-etil|-dialquilamina e sua utilizacao como anrstesicos locais
DE69614692D1 (de) Leistungsangetriebenes selbstprüfungsverfahren
FI944563L (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
FI972965A7 (fi) Uusia peptidejä, niiden valmistus ja käyttö
FI970503A7 (fi) ICAM-4-materiaaleja ja menetelmiä

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120332

Country of ref document: FI

MM Patent lapsed